CRBU
Caribou Biosciences·NASDAQ
--
--(--)
--
--(--)
Caribou Biosciences (CRBU) Revenue Breakdown
Caribou Biosciences (CRBU) Revenue Breakdown: Q2 2026 Business & Regional Performance
Caribou Biosciences (CRBU) reported total revenue of 1.50M USD in Q2 2026, with its core business segment Licensing and Other Third-Party Revenue contributing 100.00%. Regionally, United States remained the largest market, accounting for 99.53% of total revenue. Explore Caribou Biosciences's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Caribou Biosciences (CRBU) reported total revenue of 1.50M USD in Q2 2026, with its core business segment Licensing and Other Third-Party Revenue contributing 100.00%. Regionally, United States remained the largest market, accounting for 99.53% of total revenue. Explore Caribou Biosciences's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
Did Caribou Biosciences beat or miss consensus estimates last quarter?What is the market's earnings forecast for Caribou Biosciences next quarter?What were the key takeaways from Caribou Biosciences’s earnings call?What does Caribou Biosciences do and what are its main business segments?What guidance did Caribou Biosciences's management provide for the next earnings period?What is Caribou Biosciences's latest dividend and current dividend yield?What is Caribou Biosciences's gross profit margin?What factors drove the changes in Caribou Biosciences's revenue and profit?